Clinical trial
Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects…
NCT00242840 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00242840 |
|---|---|
| Title | Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir) |
| Official title | A 24 Week Phase IIIb/IV Single Arm Open Label Observational Study to Explore the Efficacy of Protease Inhibitors Given in Combination With Reverse Transcriptase Inhibitors to HIV-1 Infected Subjects With Protease Mutations Selected During Therapy With GW433908 Containing Antiretroviral Therapy |
| Lead sponsor | ViiV Healthcare, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infection, Human Immunodeficiency Virus I, HIV Infection |
| Intervention type | Drug |
| Interventions | No intervention, Observational study |
| Enrollment | 20 |
| Start date | Jun 1, 2003 |
| Primary completion | Jan 1, 2006 |
| Completion | Jan 1, 2006 |
| First posted | Oct 21, 2005 |
| Last update posted | May 30, 2017 |
| Countries | Italy, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: